{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:08:36Z","timestamp":1787731716228,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postdoctoral Research Initiation Grant for the First Affiliated Hospital of Zhengzhou University","award":["72125"],"award-info":[{"award-number":["72125"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03071-8","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T04:35:39Z","timestamp":1755837339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of lipoprotein(a) and LPA gene with calcific aortic valve disease"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3118-4407","authenticated-orcid":false,"given":"Xinyi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7945-5600","authenticated-orcid":false,"given":"Zean","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-3032","authenticated-orcid":false,"given":"Minghuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-6801","authenticated-orcid":false,"given":"Yibo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"8","key":"3071_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254\u2013743.","journal-title":"Circulation"},{"issue":"7","key":"3071_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.CIR.0000155623.48408.C5","volume":"111","author":"WC Roberts","year":"2005","unstructured":"Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111(7):920\u20135.","journal-title":"Circulation"},{"key":"3071_CR3","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","volume":"2","author":"BR Lindman","year":"2016","unstructured":"Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"3071_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.mehy.2006.07.049","volume":"68","author":"YB Li","year":"2007","unstructured":"Li YB, Hu CL, Liu J, Tang QZ, Huang CX. Calcific aortic valve disease should not be considered as a degenerative disease anymore. Med Hypotheses. 2007;68(6):1233\u20135.","journal-title":"Med Hypotheses"},{"issue":"8","key":"3071_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jcmg.2009.02.016","volume":"2","author":"DS Owens","year":"2009","unstructured":"Owens DS, Otto CM. Is it time for a new paradigm in calcific aortic valve disease? JACC Cardiovasc Imaging. 2009;2(8):928\u201330.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"3071_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","volume":"7","author":"F Duarte Lau","year":"2022","unstructured":"Duarte Lau F, Giugliano RP. Lipoprotein(a) and its significance in cardiovascular disease: a review. JAMA Cardiol. 2022;7(7):760\u20139.","journal-title":"JAMA Cardiol"},{"key":"3071_CR7","doi-asserted-by":"publisher","unstructured":"Brandts J, Ray KK. Novel and future lipid-modulating therapies for the prevention of cardiovascular disease. Nat Rev Cardiol. 2023. https:\/\/doi.org\/10.1038\/s41569-023-00860-8.","DOI":"10.1038\/s41569-023-00860-8"},{"issue":"11","key":"3071_CR8","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1194\/jlr.R071233","volume":"57","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG, Langsted A. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. J Lipid Res. 2016;57(11):1953\u201375.","journal-title":"J Lipid Res"},{"issue":"6","key":"3071_CR9","doi-asserted-by":"publisher","first-page":"e038955","DOI":"10.1161\/JAHA.124.038955","volume":"14","author":"AS Girard","year":"2025","unstructured":"Girard AS, Paulin A, Manikpurage HD, Lajeunesse E, Clavel MA, Pibarot P, Krege JH, Mathieu P, Theriault S, Arsenault BJ. Impact of lipoprotein(a) on valvular and cardiovascular outcomes in patients with calcific aortic valve stenosis. J Am Heart Assoc. 2025;14(6):e038955.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3071_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/HCO.0000000000000901","volume":"36","author":"G Hsieh","year":"2021","unstructured":"Hsieh G, Rizk T, Berman AN, Biery DW, Blankstein R. The current landscape of lipoprotein(a) in calcific aortic valvular disease. Curr Opin Cardiol. 2021;36(5):542\u20138.","journal-title":"Curr Opin Cardiol"},{"issue":"6","key":"3071_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","volume":"69","author":"S Tsimikas","year":"2017","unstructured":"Tsimikas S. A test in context: Lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol. 2017;69(6):692\u2013711.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3071_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","volume":"273","author":"F Kronenberg","year":"2013","unstructured":"Kronenberg F, Utermann G. Lipoprotein(a): resurrected by genetics. J Intern Med. 2013;273(1):6\u201330.","journal-title":"J Intern Med"},{"issue":"3","key":"3071_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","volume":"7","author":"BJ Arsenault","year":"2014","unstructured":"Arsenault BJ, Boekholdt SM, Dube MP, Rheaume E, Wareham NJ, Khaw KT, Sandhu MS, Tardif JC. Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort. Circ Cardiovasc Genet. 2014;7(3):304\u201310.","journal-title":"Circ Cardiovasc Genet"},{"issue":"12","key":"3071_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.116.026103","volume":"135","author":"BJ Cairns","year":"2017","unstructured":"Cairns BJ, Coffey S, Travis RC, Prendergast B, Green J, Engert JC, Lathrop M, Thanassoulis G, Clarke R. A replicated, genome-wide significant association of aortic stenosis with a genetic variant for Lipoprotein(a): meta-analysis of published and novel data. Circulation. 2017;135(12):1181\u20133.","journal-title":"Circulation"},{"issue":"6","key":"3071_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1109034","volume":"368","author":"G Thanassoulis","year":"2013","unstructured":"Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, Kerr KF, Pechlivanis S, Budoff MJ, Harris TB, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368(6):503\u201312.","journal-title":"N Engl J Med"},{"issue":"9","key":"3071_CR16","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/ATVBAHA.116.307311","volume":"36","author":"L Wang","year":"2016","unstructured":"Wang L, Chen J, Zeng Y, Wei J, Jing J, Li G, Su L, Tang X, Wu T, Zhou L. Functional variant in the SLC22A3-LPAL2-LPA gene cluster contributes to the severity of coronary artery disease. Arterioscler Thromb Vasc Biol. 2016;36(9):1989\u201396.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"3071_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","volume":"71","author":"S Tsimikas","year":"2018","unstructured":"Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, et al. NHLBI working group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol. 2018;71(2):177\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"3071_CR18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"9","key":"3071_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"3071_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"3071_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","volume":"63","author":"PR Kamstrup","year":"2014","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014;63(5):470\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3071_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1590\/1678-4685-gmb-2017-0371","volume":"42","author":"G Cardoso-Saldana","year":"2019","unstructured":"Cardoso-Saldana G, Fragoso JM, Lale-Farjat S, Torres-Tamayo M, Posadas-Romero C, Vargas-Alarcon G, Posadas-Sanchez R. The rs10455872-G allele of the LPA gene is associated with high lipoprotein(a) levels and increased aortic valve calcium in a Mexican adult population. Genet Mol Biol. 2019;42(3):519\u201325.","journal-title":"Genet Mol Biol"},{"issue":"9","key":"3071_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/0003319716688415","volume":"68","author":"MJ Wilkinson","year":"2017","unstructured":"Wilkinson MJ, Ma GS, Yeang C, Ang L, Strachan M, DeMaria AN, Tsimikas S, Cotter B. The prevalence of lipoprotein(a) measurement and degree of elevation among 2710 patients with calcific aortic valve stenosis in an academic echocardiography laboratory setting. Angiology. 2017;68(9):795\u20138.","journal-title":"Angiology"},{"issue":"5","key":"3071_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/ATVBAHA.115.306683","volume":"36","author":"J Cao","year":"2016","unstructured":"Cao J, Steffen BT, Budoff M, Post WS, Thanassoulis G, Kestenbaum B, McConnell JP, Warnick R, Guan W, Tsai MY. Lipoprotein(a) levels are associated with subclinical calcific aortic valve disease in White and Black individuals: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36(5):1003\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"3071_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jacc.2018.09.089","volume":"73","author":"JC Kovacic","year":"2019","unstructured":"Kovacic JC, Dimmeler S, Harvey RP, Finkel T, Aikawa E, Krenning G, Baker AH. Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(2):190\u2013209.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"3071_CR26","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1161\/ATVBAHA.120.314789","volume":"40","author":"K Xu","year":"2020","unstructured":"Xu K, Xie S, Huang Y, Zhou T, Liu M, Zhu P, Wang C, Shi J, Li F, Sellke FW, et al. Cell-type transcriptome atlas of human aortic valves reveal cell heterogeneity and endothelial to mesenchymal transition involved in calcific aortic valve disease. Arterioscler Thromb Vasc Biol. 2020;40(12):2910\u201321.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"3071_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41569-023-00845-7","volume":"20","author":"LM Moncla","year":"2023","unstructured":"Moncla LM, Briend M, Bosse Y, Mathieu P. Calcific aortic valve disease: mechanisms, prevention and treatment. Nat Rev Cardiol. 2023;20(8):546\u201359.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"3071_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2015.07.008","volume":"242","author":"J Hjortnaes","year":"2015","unstructured":"Hjortnaes J, Shapero K, Goettsch C, Hutcheson JD, Keegan J, Kluin J, Mayer JE, Bischoff J, Aikawa E. Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosis. 2015;242(1):251\u201360.","journal-title":"Atherosclerosis"},{"issue":"9","key":"3071_CR29","doi-asserted-by":"publisher","first-page":"e006339","DOI":"10.1161\/JAHA.117.006339","volume":"6","author":"A Rutkovskiy","year":"2017","unstructured":"Rutkovskiy A, Malashicheva A, Sullivan G, Bogdanova M, Kostareva A, Stenslokken KO, Fiane A, Vaage J. Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification. J Am Heart Assoc. 2017;6(9):e006339.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"3071_CR30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.110.234138","volume":"108","author":"JD Miller","year":"2011","unstructured":"Miller JD, Weiss RM, Heistad DD. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res. 2011;108(11):1392\u2013412.","journal-title":"Circ Res"},{"issue":"7","key":"3071_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/jamacardio.2019.1581","volume":"4","author":"N Perrot","year":"2019","unstructured":"Perrot N, Theriault S, Dina C, Chen HY, Boekholdt SM, Rigade S, Despres AA, Poulin A, Capoulade R, Le Tourneau T, et al. Genetic variation in LPA, calcific aortic valve stenosis in patients undergoing cardiac surgery, and familial risk of aortic valve microcalcification. JAMA Cardiol. 2019;4(7):620\u20137.","journal-title":"JAMA Cardiol"},{"issue":"40","key":"3071_CR32","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1093\/eurheartj\/ehaa070","volume":"41","author":"M Nazarzadeh","year":"2020","unstructured":"Nazarzadeh M, Pinho-Gomes AC, Bidel Z, Dehghan A, Canoy D, Hassaine A, Ayala Solares JR, Salimi-Khorshidi G, Smith GD, Otto CM, et al. Plasma lipids and risk of aortic valve stenosis: a mendelian randomization study. Eur Heart J. 2020;41(40):3913\u201320.","journal-title":"Eur Heart J"},{"issue":"6","key":"3071_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","volume":"5","author":"BA Bergmark","year":"2020","unstructured":"Bergmark BA, O\u2019Donoghue ML, Murphy SA, Kuder JF, Ezhov MV, Ceska R, Gouni-Berthold I, Jensen HK, Tokgozoglu SL, Mach F, et al. An exploratory analysis of proprotein convertase subtilisin\/kexin type 9 inhibition and aortic stenosis in the FOURIER trial. JAMA Cardiol. 2020;5(6):709\u201313.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"3071_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","volume":"49","author":"LM Moura","year":"2007","unstructured":"Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Goncalves F, Rajamannan NM. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49(5):554\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"3071_CR35","doi-asserted-by":"publisher","first-page":"877140","DOI":"10.3389\/fcvm.2022.877140","volume":"9","author":"Q Liu","year":"2022","unstructured":"Liu Q, Yu Y, Xi R, Li J, Lai R, Wang T, Fan Y, Zhang Z, Xu H, Ju J. Association between lipoprotein(a) and calcific aortic valve disease: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:877140.","journal-title":"Front Cardiovasc Med"},{"key":"3071_CR36","doi-asserted-by":"publisher","unstructured":"Bourgeois R, Bourgault J, Despres AA, Perrot N, Guertin J, Girard A, Mitchell PL, Gotti C, Bourassa S, Scipione CA, et al. Lipoprotein proteomics and aortic valve transcriptomics identify biological pathways linking lipoprotein(a) levels to aortic stenosis. Metabolites. 2021. https:\/\/doi.org\/10.3390\/metabo11070459.","DOI":"10.3390\/metabo11070459"},{"issue":"6","key":"3071_CR37","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1172\/JCI117292","volume":"93","author":"DJ Rader","year":"1994","unstructured":"Rader DJ, Cain W, Ikewaki K, Talley G, Zech LA, Usher D, Brewer HB Jr. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest. 1994;93(6):2758\u201363.","journal-title":"J Clin Invest"},{"issue":"2","key":"3071_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.atherosclerosis.2015.07.034","volume":"242","author":"M Rattazzi","year":"2015","unstructured":"Rattazzi M, Pauletto P. Valvular endothelial cells: guardians or destroyers of aortic valve integrity? Atherosclerosis. 2015;242(2):396\u20138.","journal-title":"Atherosclerosis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03071-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:06:47Z","timestamp":1757444807000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03071-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3071"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03071-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval number: 2024-KY-1600-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"787"}}